Literature DB >> 8201089

Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure.

Y Wakabayashi1, T Kikuno, T Ohwada, R Kikawada.   

Abstract

OBJECTIVE: Myoglobin kinetics of removal from the circulation were studied in patients following massive rhabdomyolysis, to see if myoglobin remains for long in the circulation in the anuric state and if myoglobin elimination was affected by therapeutic manipulation such as haemofiltration or haemodialysis.
DESIGN: Randomised and controlled study.
SETTING: Intensive care unit of a tertiary care teaching hospital. PATIENTS: 26 patients of rhabdomyolysis whose serum myoglobin exceeded more than 500 nmol/l. Thirteen patients developed acute renal failure and underwent treatment with blood purification (Group HD). The remaining 13 patients did not require treatment with blood purification (control subjects, Group non-HD).
INTERVENTIONS: In patients of group HD, twelve were treated with haemofiltration and/or haemodialysis. One was treated with peritoneal dialysis. The patient of group non-HD were treated with fluid infusion alone. MEASUREMENTS AND
RESULTS: The serum concentrations of myoglobin were serially determined. The highest levels of myoglobin was 1641 +/- 484 nmol/l (mean +/- SEM) in the group non-HD and were 8957 +/- 2300 in the group HD. In the group non-HD, the blood myoglobin fell exponentially once myoglobin release into the circulation ceased. This was also noted in the group HD. The exponential decrease was observed even on the days when the patient passed little urine or treatment with blood purification was not performed.
CONCLUSION: In patients with massive myoglobinaemia, the blood myoglobin rapidly fell independent of renal function or any therapeutic manipulation. The results indicate that extrarenal factors played a major role in disposing circulating myoglobin in such patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201089     DOI: 10.1007/bf01707664

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  12 in total

1.  EXPERIMENTAL INVESTIGATION OF THE METABOLISM OF MYOGLOBIN.

Authors:  T AMAKO; J KOGA; A KOBAYASHI; S URAKADO; J TOKUNAGA
Journal:  Kyushu J Med Sci       Date:  1963-10

2.  A STUDY OF SHOCK: ACIDOSIS AND THE DECLAMPING PHENOMENON.

Authors:  A E BAUE; W W MCCLERKIN
Journal:  Ann Surg       Date:  1965-01       Impact factor: 12.969

3.  Arterial embolism with acute massive ischemic myopathy and myoglobinuria: evaluation of a hitherto unreported syndrome with report of two cases.

Authors:  H HAIMOVICI
Journal:  Surgery       Date:  1960-05       Impact factor: 3.982

4.  [The determination of serum and urine myoglobin].

Authors:  H Naka; K Nogami; S Sekine
Journal:  Rinsho Byori       Date:  1991-02

5.  Plasma exchange in rhabdomyolysis.

Authors:  J J Cornelissen; W Haanstra; H J Haarman; R H Derksen
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

6.  Myoglobinuria, hemoglobinuria, and acute renal failure.

Authors:  R W Hamilton; M B Hopkins; Z K Shihabi
Journal:  Clin Chem       Date:  1989-08       Impact factor: 8.327

7.  [Evaluation of the rapid method for the quantitation of serum myoglobin by the latex agglutination turbidimetry and studies on the changes in serum levels with acute myocardial infarction].

Authors:  Y Kawata; S Fujita; Y Katayama; T Matsuyama
Journal:  Rinsho Byori       Date:  1989-06

8.  Nontraumatic rhabdomyolysis and acute renal failure.

Authors:  R A Grossman; R W Hamilton; B M Morse; A S Penn; M Goldberg
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

9.  The spectrum of rhabdomyolysis.

Authors:  P A Gabow; W D Kaehny; S P Kelleher
Journal:  Medicine (Baltimore)       Date:  1982-05       Impact factor: 1.889

10.  Myoglobin turnover--influence of renal and extrarenal factors.

Authors:  R Hällgren; F A Karlsson; L E Roxin; P Venge
Journal:  J Lab Clin Med       Date:  1978-02
View more
  8 in total

1.  Neuroleptic malignant syndrome in a patient with head injury.

Authors:  J L Perez-Vela; M Sanchez Casado; J A Sanchez-Izquierdo Riera; A Ambros Checa; R Caballero Cubedo; E Alted Lopez
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

Review 2.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

3.  Prognostic value of serum myoglobin in patients after cardiac surgery.

Authors:  Denis Hofmann; Marco Buettner; Florian Rissner; Manuela Wahl; Samir G Sakka
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

4.  Rhabdomyolysis: risk factors and incidence in polytrauma patients in the absence of major disasters.

Authors:  A Sousa; J A Paiva; S Fonseca; F Raposo; L Valente; D Vyas; O Ribeiro; R Pinto
Journal:  Eur J Trauma Emerg Surg       Date:  2012-10-25       Impact factor: 3.693

5.  Exertional rhabdomyolysis in a 21-year-old healthy man resulting from lower extremity training: A case report.

Authors:  Fenfen Peng; Xuexin Lin; Ling Zhi Sun; Weidong Zhou; Yihua Chen; Peilin Li; Ting Chen; Jiayu Wu; Zhaozhong Xu; Haibo Long
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.

Authors:  Lisa Kodadek; Samuel P Carmichael Ii; Anupamaa Seshadri; Abhijit Pathak; Jason Hoth; Rachel Appelbaum; Christopher P Michetti; Richard P Gonzalez
Journal:  Trauma Surg Acute Care Open       Date:  2022-01-27

7.  Renal Replacement Therapy in Acute Kidney Failure due to Rhabdomyolysis.

Authors:  G Maggi; F Quinteros Hinojosa; M J Villagran; E Guasch Arévalo; F Gilsanz Rodríguez
Journal:  Case Rep Crit Care       Date:  2012-04-17

8.  Nonobstructive Acute Renal Failure with a Large Solitary Fibroid.

Authors:  Rayan Elkattah; Zineb Mashak; Blakele Bakker; Shanti Mohling; Ali Yilmaz; Stephen DePasquale; Todd Boren
Journal:  Case Rep Obstet Gynecol       Date:  2016-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.